Relative contributions of lipooligosaccharide inner and outer core modifications to nontypeable haemophilus influenzae pathogenesis

Infection and Immunity

Volumn 81, Issue 11, 2013, Pages 4100-4111

  Morey, Pau ^a,b   Viadas, Cristina ^a,b,c   Euba, Begoña ^b,c   Hood, Derek W ^d   Barberán, Montserrat ^e   Gil, Carmen ^c   Grilló, María Jesús ^c   Bengoechea, José Antonio ^a,b   Garmendia, Junkal ^a,b,c  

^a Laboratory Microbial Pathogenesis   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c CSIC   (Spain)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSIDAD DE ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; HEPTOSE; LIPOOLIGOSACCHARIDE; PHOSPHORYLCHOLINE; PROTEIN DERIVATIVE; SIALIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CHEMICAL MODIFICATION; CONTROLLED STUDY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOFILMS; BRONCHOPNEUMONIA; CELL ADHESION; DISEASE MODELS, ANIMAL; ENDOTOXINS; EPITHELIAL CELLS; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; LIPOPOLYSACCHARIDES; METABOLIC NETWORKS AND PATHWAYS; MICE; MUTATION; VIRULENCE; VIRULENCE FACTORS;

EID: 84886800337     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00492-13     Document Type: Article

References (67)

1. Agrawal A, Murphy TF. 2011. Haemophilus influenzae infections in the H. influenzae type b conjugate vaccine era. J. Clin. Microbiol. 49:3728-3732.
2. Apicella MA. 2012. Nontypeable Haemophilus influenzae: the role of N-acetyl-5-neuraminic acid in biology. Front. Cell. Infect. Microbiol. 2:19. doi:10.3389/fcimb.2012.00019.
3. Hallström T, Riesbeck K. 2010. Haemophilus influenzae and the complement system. Trends Microbiol. 18:258-265.
4. Swords WE. 2012. Nontypeable Haemophilus influenzae biofilms: role in chronic airway infections. Front. Cell. Infect. Microbiol. 2:97. doi:10.3389 /fcimb.2012.00097.
5. Schweda EK, Richards JC, Hood DW, Moxon ER. 2007. Expression and structural diversity of the lipopolysaccharide of Haemophilus influenzae: implication in virulence. Int. J. Med. Microbiol. 297:297-306.
6. Gronow S, Brabetz W, Lindner B, Brade H. 2005. OpsX from Haemophilus influenzae represents a novel type of heptosyltransferase I in lipopolysaccharide biosynthesis. J. Bacteriol. 187:6242-6247.
7. Deadman ME, Lundstrom SL, Schweda EK, Moxon ER, Hood DW. 2006. Specific amino acids of the glycosyltransferase LpsA direct the addition of glucose or galactose to the terminal inner core heptose of Haemophilus influenzae lipopolysaccharide via alternative linkages. J. Biol. Chem. 281:29455-29467.
8. Hood DW, Deadman ME, Cox AD, Makepeace K, Martin A, Richards JC, Moxon ER. 2004. Three genes, lgtF, lic2C and lpsA, have a primary role in determining the pattern of oligosaccharide extension from the inner core of Haemophilus influenzae LPS. Microbiology 150:2089-2097.
9. Mansson M, Bauer SH, Hood DW, Richards JC, Moxon ER, Schweda EK. 2001. A new structural type for Haemophilus influenzae lipopolysaccharide. Structural analysis of the lipopolysaccharide from nontypeable Haemophilus influenzae strain 486. Eur. J. Biochem. 268:2148-2159.
10. Weiser JN, Shchepetov M, Chong ST. 1997. Decoration of lipopolysaccharide with phosphorylcholine: a phase-variable characteristic of Haemophilus influenzae. Infect. Immun. 65:943-950.
11. High NJ, Deadman ME, Moxon ER. 1993. The role of a repetitive DNA motif (5=-CAAT-3=) in the variable expression of the Haemophilus influenzae lipopolysaccharide epitope α Gal(1-4)β Gal. Mol. Microbiol. 9:1275-1282.
12. Fox KL, Cox AD, Gilbert M, Wakarchuk WW, Li J, Makepeace K, Richards JC, Moxon ER, Hood DW. 2006. Identification of a bifunctional lipopolysaccharide sialyltransferase in Haemophilus influenzae: incorporation of disialic acid. J. Biol. Chem. 281:40024-40032.
13. Hood DW, Cox AD, Gilbert M, Makepeace K, Walsh S, Deadman ME, Cody A, Martin A, Mansson M, Schweda EK, Brisson JR, Richards JC, Moxon ER, Wakarchuk WW. 2001. Identification of a lipopolysaccharide α-2,3-sialyltransferase from Haemophilus influenzae. Mol. Microbiol. 39:341-350.
14. Hood DW, Makepeace K, Deadman ME, Rest RF, Thibault P, Martin A, Richards JC, Moxon ER. 1999. Sialic acid in the lipopolysaccharide of Haemophilus influenzae: strain distribution, influence on serum resistance and structural characterization. Mol. Microbiol. 33:679-692.
15. Jones PA, Samuels NM, Phillips NJ, Munson RS, Jr, Bozue JA, Arseneau JA, Nichols WA, Zaleski A, Gibson BW, Apicella MA. 2002. Haemophilus influenzae type b strain A2 has multiple sialyltransferases involved in lipooligosaccharide sialylation. J. Biol. Chem. 277:14598-14611.
16. Lysenko E, Richards JC, Cox AD, Stewart A, Martin A, Kapoor M, Weiser JN. 2000. The position of phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae affects binding and sensitivity to C-reactive protein-mediated killing. Mol. Microbiol. 35:234-245.
17. Weiser JN, Pan N. 1998. Adaptation of Haemophilus influenzae to acquired and innate humoral immunity based on phase variation of lipopolysaccharide. Mol. Microbiol. 30:767-775.
18. Weiser JN, Pan N, McGowan KL, Musher D, Martin A, Richards J. 1998. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J. Exp. Med. 187:631-640.
19. Clark SE, Snow J, Li J, Zola TA, Weiser JN. 2012. Phosphorylcholine allows for evasion of bactericidal antibody by Haemophilus influenzae. PLoS Pathog. 8:e1002521. doi:10.1371/journal.ppat.1002521.
20. Lysenko ES, Gould J, Bals R, Wilson JM, Weiser JN. 2000. Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract. Infect. Immun. 68:1664-1671.
21. Hong W, Mason K, Jurcisek J, Novotny L, Bakaletz LO, Swords WE. 2007. Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media. Infect. Immun. 75:958-965.
22. Hong W, Pang B, West-Barnette S, Swords WE. 2007. Phosphorylcholine expression by nontypeable Haemophilus influenzae correlates with maturation of biofilm communities in vitro and in vivo. J. Bacteriol. 189: 8300-8307.
23. West-Barnette S, Rockel A, Swords WE. 2006. Biofilm growth increases phosphorylcholine content and decreases potency of nontypeable Haemophilus influenzae endotoxins. Infect. Immun. 74:1828-1836.
24. Swords WE, Ketterer MR, Shao J, Campbell CA, Weiser JN, Apicella MA. 2001. Binding of the non-typeable Haemophilus influenzae lipooligosaccharide to the PAF receptor initiates host cell signalling. Cell. Microbiol. 3:525-536.
25. Pang B, Winn D, Johnson R, Hong W, West-Barnette S, Kock N, Swords WE. 2008. Lipooligosaccharides containing phosphorylcholine delay pulmonary clearance of nontypeable Haemophilus influenzae. Infect. Immun. 76:2037-2043.
26. Griffin R, Bayliss CD, Herbert MA, Cox AD, Makepeace K, Richards JC, Hood DW, Moxon ER. 2005. Digalactoside expression in the lipopolysaccharide of Haemophilus influenzae and its role in intravascular survival. Infect. Immun. 73:7022-7026.
27. Figueira MA, Ram S, Goldstein R, Hood DW, Moxon ER, Pelton SI. 2007. Role of complement in defense of the middle ear revealed by restoring the virulence of nontypeable Haemophilus influenzae siaB mutants. Infect. Immun. 75:325-333.
28. Greiner LL, Watanabe H, Phillips NJ, Shao J, Morgan A, Zaleski A, Gibson BW, Apicella MA. 2004. Nontypeable Haemophilus influenzae strain 2019 produces a biofilm containing N-acetylneuraminic acid that may mimic sialylated O-linked glycans. Infect. Immun. 72:4249-4260.
29. Jurcisek J, Greiner L, Watanabe H, Zaleski A, Apicella MA, Bakaletz LO. 2005. Role of sialic acid and complex carbohydrate biosynthesis in biofilm formation by nontypeable Haemophilus influenzae in the chinchilla middle ear. Infect. Immun. 73:3210-3218.
30. Swords WE, Moore ML, Godzicki L, Bukofzer G, Mitten MJ, VonCannon J. 2004. Sialylation of lipooligosaccharides promotes biofilm formation by nontypeable Haemophilus influenzae. Infect. Immun. 72:106-113.
31. Bouchet V, Hood DW, Li J, Brisson JR, Randle GA, Martin A, Li Z, Goldstein R, Schweda EK, Pelton SI, Richards JC, Moxon ER. 2003. Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media. Proc. Natl. Acad. Sci. U. S. A. 100:8898-8903.
32. Martí-Lliteras P, Regueiro V, Morey P, Hood DW, Saus C, Sauleda J, Agusti AG, Bengoechea JA, Garmendia J. 2009. Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke. Infect. Immun. 77:4232-4242.
33. Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM, et al. 1995. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496-512.
34. Harrison A, Dyer DW, Gillaspy A, Ray WC, Mungur R, Carson MB, Zhong H, Gipson J, Gipson M, Johnson LS, Lewis L, Bakaletz LO, Munson RS, Jr. 2005. Genomic sequence of an otitis media isolate of nontypeable Haemophilus influenzae: comparative study with H. influenzae serotype d, strain KW20. J. Bacteriol. 187:4627-4636.
35. Allen S, Zaleski A, Johnston JW, Gibson BW, Apicella MA. 2005. Novel sialic acid transporter of Haemophilus influenzae. Infect. Immun. 73: 5291-5300.
36. Herriott RM, Meyer EY, Vogt M, Modan M. 1970. Defined medium for growth of Haemophilus influenzae. J. Bacteriol. 101:513-516.
37. Johnston JW, Zaleski A, Allen S, Mootz JM, Armbruster D, Gibson BW, Apicella MA, Munson RS, Jr. 2007. Regulation of sialic acid transport and catabolism in Haemophilus influenzae. Mol. Microbiol. 66:26-39.
38. Lesse AJ, Campagnari AA, Bittner WE, Apicella MA. 1990. Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine- sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J. Immunol. Methods 126:109-117.
39. Swords WE, Buscher BA, Ver Steeg Ii K, Preston A, Nichols WA, Weiser JN, Gibson BW, Apicella MA. 2000. Non-typeable Haemophilusinfluenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol. Microbiol. 37:13-27.
40. Llobet E, Campos MA, Gimenez P, Moranta D, Bengoechea JA. 2011. Analysis of the networks controlling the antimicrobial-peptidedependent induction of Klebsiella pneumoniae virulence factors. Infect. Immun. 79:3718-3732.
41. Morey P, Cano V, Marti-Lliteras P, Lopez-Gomez A, Regueiro V, Saus C, Bengoechea JA, Garmendia J. 2011. Evidence for a non-replicative intracellular stage of nontypable Haemophilus influenzae in epithelial cells. Microbiology 157:234-250.
42. Brogden KA. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
43. Hancock RE, Chapple DS. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1317-1323.
44. Nicolas P, Mor A. 1995. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu. Rev. Microbiol. 49:277-304.
45. Vaara M. 1992. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56:395-411.
46. Evans ME, Feola DJ, Rapp RP. 1999. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann. Pharmacother. 33:960-967.
47. Hermsen ED, Sullivan CJ, Rotschafer JC. 2003. Polymyxins: pharmacology, pharmacokinetics, pharmacodynamics, and clinical applications. Infect. Dis. Clin. North Am. 17:545-562.
48. Agerberth B, Grunewald J, Castanos-Velez E, Olsson B, Jornvall H, Wigzell H, Eklund A, Gudmundsson GH. 1999. Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am. J. Respir. Crit. Care Med. 160:283-290.
49. Hendrixson DR, St Geme JW, III. 1998. The Haemophilus influenzae Hap serine protease promotes adherence and microcolony formation, potentiated by a soluble host protein. Mol. Cell 2:841-850.
50. Vergara-Irigaray M, Valle J, Merino N, Latasa C, Garcia B, Ruiz de Los Mozos I, Solano C, Toledo-Arana A, Penades JR, Lasa I. 2009. Relevant role of fibronectin-binding proteins in Staphylococcus aureus biofilmassociated foreign-body infections. Infect. Immun. 77:3978-3991.
51. Clementi CF, Murphy TF. 2011. Non-typeable Haemophilus influenzae invasion and persistence in the human respiratory tract. Front. Cell. Infect. Microbiol. 1:1. doi:10.3389/fcimb.2011.00001.
52. López-Gómez A, Cano V, Moranta D, Morey P, Garcia del Portillo F, Bengoechea JA, Garmendia J. 2012. Host cell kinases, α5 and β1 integrins, and Rac1 signalling on the microtubule cytoskeleton are important for non-typable Haemophilus influenzae invasion of respiratory epithelial cells. Microbiology 158:2384-2398.
53. Regueiro V, Campos MA, Morey P, Sauleda J, Agusti AG, Garmendia J, Bengoechea JA. 2009. Lipopolysaccharide-binding protein and CD14 are increased in the bronchoalveolar lavage fluid of smokers. Eur. Respir. J. 33:273-281.
54. Gawronski JD, Wong SM, Giannoukos G, Ward DV, Akerley BJ. 2009. Tracking insertion mutants within libraries by deep sequencing and a genome-wide screen for Haemophilus genes required in the lung. Proc. Natl. Acad. Sci. U. S. A. 106:16422-16427.
55. Pang B, Hong W, Kock ND, Swords WE. 2012. Dps promotes survival of nontypeable Haemophilus influenzae in biofilm communities in vitro and resistance to clearance in vivo. Front. Cell. Infect. Microbiol. 2:58. doi:10 .3389/fcimb.2012.00058.
56. Pang B, Hong W, West-Barnette SL, Kock ND, Swords WE. 2008. Diminished ICAM-1 expression and impaired pulmonary clearance of nontypeable Haemophilus influenzae in a mouse model of chronic obstructive pulmonary disease/emphysema. Infect. Immun. 76:4959-4967.
57. Rosadini CV, Gawronski JD, Raimunda D, Arguello JM, Akerley BJ. 2011. A novel zinc binding system, ZevAB, is critical for survival of nontypeable Haemophilus influenzae in a murine lung infection model. Infect. Immun. 79:3366-3376.
58. Spahich NA, Hood DW, Moxon ER, St Geme JW, III. 2012. Inactivation of Haemophilus influenzae lipopolysaccharide biosynthesis genes interferes with outer membrane localization of the hap autotransporter. J. Bacteriol. 194:1815-1822.
59. Martí-Lliteras P, Lopez-Gomez A, Mauro S, Hood DW, Viadas C, Calatayud L, Morey P, Servin A, Linares J, Oliver A, Bengoechea JA, Garmendia J. 2011. Nontypable Haemophilus influenzae displays a prevalent surface structure molecular pattern in clinical isolates. PLoS One 6:e21133. doi:10.1371/journal.pone.0021133.
60. Hogg JS, Hu FZ, Janto B, Boissy R, Hayes J, Keefe R, Post JC, Ehrlich GD. 2007. Characterization and modeling of the Haemophilus influenzae core and supragenomes based on the complete genomic sequences of Rd and 12 clinical nontypeable strains. Genome Biol. 8:R103. doi:10.1186/gb -2007-8-6-r103.
61. Wong SM, Akerley BJ. 2012. Genome-scale approaches to identify genes essential for Haemophilus influenzae pathogenesis. Front. Cell. Infect. Microbiol. 2:23. doi:10.3389/fcimb.2012.00023.
62. Iwata T, Chiku K, Amano K, Kusumoto M, Ohnishi-Kameyama M, Ono H, Akiba M. 2013. Effects of lipooligosaccharide inner core truncation on bile resistance and chick colonization by Campylobacter jejuni. PLoS One 8:e56900. doi:10.1371/journal.pone.0056900.
63. Naito M, Frirdich E, Fields JA, Pryjma M, Li J, Cameron A, Gilbert M, Thompson SA, Gaynor EC. 2010. Effects of sequential Campylobacter jejuni 81-176 lipooligosaccharide core truncations on biofilm formation, stress survival, and pathogenesis. J. Bacteriol. 192:2182-2192.
64. Murphy TF, Kirkham C. 2002. Biofilm formation by nontypeable Haemophilus influenzae: strain variability, outer membrane antigen expression and role of pili. BMC Microbiol. 2:7. doi:10.1186/1471-2180-2-7.
65. McLaughlin R, Spinola SM, Apicella MA. 1992. Generation of lipooligosaccharide mutants of Haemophilus influenzae type b. J. Bacteriol. 174: 6455-6459.
66. Duerr CU, Zenk SF, Chassin C, Pott J, Gutle D, Hensel M, Hornef MW. 2009. O-antigen delays lipopolysaccharide recognition and impairs antibacterial host defense in murine intestinal epithelial cells. PLoS Pathog. 5:e1000567. doi:10.1371/journal.ppat.1000567.
67. Clark SE, Eichelberger KR, Weiser JN. 2013. Evasion of killing by human antibody and complement through multiple variations in the surface oligosaccharide of Haemophilus influenzae. Mol. Microbiol. 88:603-618.